Header H1

Lorem ipsum dolor sit amet, adipiscing elit. Sed quis nisl scele risque, luctus metus sed eget dictum ante suspendisse potential. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Typography


Sub-Header H2

Sub-Header H3

Sub-Header H4

Sub-Header H5
Sub-Header H6

 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum vitae commodo leo. Nam aliquet mauris congue libero ornare egestas. In hac habitasse platea dictumst. Donec convallis hendrerit pharetra. Maecenas quis lectus dapibus orci fringilla accumsan. Cras finibus purus at vehicula pharetra. Vestibulum vel molestie loremBody Text

Lorem ipsum dolor sit amet, consectetuer elit,sed diam nonummy nibh tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit.

Michael Ackerman  |  Allergan
Unordered List
  • Praesent auctor ex eu nibh venenatis eleifend. Maecenas ac neque et neque sodales euismod. Nam vehicula sodales mollis. Duis dui sem, finibus vitae ultrices eu.
  • Praesent auctor ex eu nibh venenatis eleifend. Maecenas ac neque et neque sodales euismod. Nam vehicula sodales mollis. Duis dui sem, finibus vitae ultrices eu.
  • Praesent ipsum lectus, cursus id metus ac, mollis bibendum felis. Duis in suscipit tellus.
  • Praesent auctor ex eu nibh venenatis eleifend. Maecenas ac neque et neque sodales euismod. Nam vehicula sodales mollis. Duis dui sem, finibus vitae ultrices eu.
Ordered List
  1. Praesent auctor ex eu nibh venenatis eleifend. Maecenas ac neque et neque sodales euismod. Nam vehicula sodales mollis. Duis dui sem, finibus vitae ultrices eu.
  2. Praesent auctor ex eu nibh venenatis eleifend. Maecenas ac neque et neque sodales euismod. Nam vehicula sodales mollis. Duis dui sem, finibus vitae ultrices eu.
  3. Praesent ipsum lectus, cursus id metus ac, mollis bibendum felis. Duis in suscipit tellus.
  4. Praesent auctor ex eu nibh venenatis eleifend. Maecenas ac neque et neque sodales euismod. Nam vehicula sodales mollis. Duis dui sem, finibus vitae ultrices eu.

 

Buttons


Primary Button

Primary Button Inverse

Primary Button Small 

Primary Button Small Inverse

Secondary Button

Secondary Button Inverse

Secondary Button Small

Secondary Button Small Inverse

More Link

 

Form Fields


 

Web Elements


Table
Column Header Column Header Column Header
Sub Header
Lorem Ipsum Item Lorem Ipsum Item Lorem Ipsum Item
Lorem Ipsum Item Lorem Ipsum Item Lorem Ipsum Item
Lorem Ipsum Item Lorem Ipsum Item Lorem Ipsum Item
Accordions

PUT YOUR CONTENT HERE

PUT YOUR CONTENT HERE

PUT YOUR CONTENT HERE

Listings


Veeva Vault CTMS Gains Momentum as Industry Moves to Unify Clinical Applications and Processes

Articles, News
CTMS cloud application streamlines trial management and delivers end-to-end visibility of clinical trials on one platform

Nicox receives FDA approval of ZERVIATE (cetirizine ophthalmic solution) 0.24%

Articles
ZERVIATE was established in three randomized, double-masked, placebo-controlled, conjunctival antigen challenge (Ora-CAC®3 model of allergic conjunctivitis)

Recognizing Additional Value in China

Articles
Ophthalmic Product Development Insights

Dry Eye: Beyond the Usual Suspects

Articles
Digging deeper into the types of patients who get dry eye and the situations that can bring it on.

Ocular Gene Therapy Trials Advance

Articles
Results of the first phase 3 trial in this field were announced.

Okogen Secures Ora to Conduct Clinical and Regulatory Development of OKG-0301 for Adenoviral Conjunctivitis

Articles
Okogen, Inc. to present at 2017 Biotech Showcase

Convertible Financing 101 for the Entrepreneur

Articles
Ophthalmic Product Development Insights

Cutting and Splicing For CRISPR Vision

Articles
How this particular type of gene editing works and a discussion of its potential uses in the future.

Noveome Initiates Phase 2 Clinical Trial of ST266 for the Treatment of Allergic Conjunctivitis

Articles
Second Disease Indication Shows Versatility of Paracrine Signaling Solution

Accommodation For the Aging Eye

Articles
Like death and taxes, presbyopia is one of life’s certainties, an inevitable companion to the aging process

Right Between Your Eyes

Articles
A look at ocular/nasal interactions and how they can affect our
pharmaceutical therapies.

Visual Function Biomarkers Needed for Dry AMD

Articles
Early detection may allow treatment, and possibly reversal. Part 2 of a two-part series.

Objective: Symptomatic Assessment Strategies

Articles
Symptom scores can be helpful when treating dry eye, but
constructing good questionnaires can be a challenge.

Site Selection Success

Articles
When it comes to your site’s qualifications, you must be forthcoming with study sponsors.

How Do You Quantify The Qualitative?

Articles
The purpose of any scale is to provide a means to measure a trait, a physical change or any parameter not readily amenable to direct quantitation.

An Interdisciplinary Approach to Addressing an Unmet Need

Articles
Ophthalmic Product Development Insights

SkQ1 Ophthalmic Solution for Dry Eye Treatment

Articles
Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model

The Impact Study

Articles
A prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

The Hottest Topics From ARVO 2016

Articles
A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.

ARVO 2016 meeting paves path for personalized medicine

Articles
Genetic approaches, stem cells, anti-VEGF therapy, presbyopia among innovative research

Combination Therapies: Recipes for Success

Articles
Putting two drugs together in one formulation can sometimes achieve better results than either agent can by itself.

ADVANCES IN THERAPY FOR DRY AMD

Articles
Numerous approaches to treatment of dry AMD are under development.

Choosing and Planning Your Exit Strategy

Articles
Ophthalmic Product Development Insights

An Informed Patient is A Better Patient

Articles
Explaining both the demands and potential rewards of a clinical trial can make patients more
likely to participate fully in the protocol.

The Form and Function Of Meibomian Glands

Articles
A discussion of gland mechanisms, how they can go awry and
what you can do to nurse them back to health.

Ora Appoints David Hollander, M.D., M.B.A., As Chief Medical Officer

Articles, News
Dr. Hollander joins Ora after 10 years as industry leader at Allergan.
Meet Ora’s New Chief Medical Officer at ARVO

Clinical Studies in Ocular Imaging

Articles
Involvement in diagnostic clinical trials can assist you
in bringing a new level of expertise to your staff.

Understanding Blue Light

Articles
Exposure to certain wavelengths of blue light carries potential blinding effects and a
link to AMD.

Caring for the Eye’s Gatekeepers

Articles
A look at the etiology, signs and symptoms of blepharitis, as well as strategies for treatment.

Diagnosing dry eye: It’s now a fine art

Articles
Research has led to better, more diverse ways to reach a diagnosis, let alone more knowledge about DED itself.

Ora Names Simon Chandler to Lead Regulatory And Clinical Operations In Europe

Articles, News
Ora, ophthalmic leader, deepens European foothold as part of Global expansion

Ora presenting 11 posters at this year’s ARVO conference

Articles, News
Come visit Ora at booth #2131 or set up a meeting with us to learn about how we can help bring your product from concept to approval.

What clinicians should know about ocular allergies

Articles
Taking a fresh look at up-to-the-minute treatment modalities for managing patients’ symptoms

Oxidative Stress Reduction for Dry Eye

Articles
Antioxidants’ effects on harmful reactive oxygen species may be helpful in the fight against dry eye.

Wintering with Ocular Allergies

Articles
A look at the attributes of perennial allergy and therapies designed to combat the chronic inflammation it engenders.

Physician-Entrepreneur: From Concept to Development

Articles, News
In this installment, we review another innovative project, exploring the progression of a product's development, starting with the initial germination of the idea based on clinical observations.

Nicox out-licenses OTC asset AC-120 to Ora, Inc.

Articles, News

Ocular Drug Delivery: Targeting the Posterior Segment

Articles
Many efforts are under way to improve drug delivery to the back of the eye.

Neuropathic Pain: The Artifice of Dry Eye

Articles
A look at neuropathic pain and its relationship to dry-eye diagnosis and therapeutic strategies.

Ocular Drug Delivery

Articles
Challenges of Matching New Technologies with Drug Pharmacokinetics

Working Magic with Pharmacokinetics

Articles
How increasing the absorption, bioavailability and/or retention of a drug can result in better efficacy without greater side effects.

It’s the Thought that Counts

Articles
Ophthalmic Product Development Insights

Bring Them to Tears With Your Treatment

Articles
New compounds, especially those derived from hyaluronic acid, may change the game of dry-eye treatment.

Interpreting Clinical Trial Results

Articles
Let the data be your guide when considering a
new device for your practice.

Clinical Trials at Our Fingertips: A Salute to Technology

Articles
Technological integration seeps into the clinical research space.

The Hows and Whys of Pharmacokinetics

Articles
Simple attributes, such as how much drug can reach its target
and how long it stays there, make a big difference in outcomes.

Delving into the Dry-Eye Pipeline

Articles
Novel compounds of all sorts, from anti-inflammatories to receptor inhibitors, are on the way.

A Glance at Retina Presentations at ARVO 2015

Articles
Judging by the topics covered, there is no shortage of new therapies in development.

Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis

Articles
DEXTENZA successfully met primary endpoint for treatment of ocular itching associated with allergic conjunctivitis

Should You Participate in Clinical Research?

Articles
Thinking of getting involved in a clinical trial? Here is some food for thought to help you make an informed decision.

New Balance Reach the Beach Relay

Articles, News
The New Balance Reach The Beach (RTB) Relay is one of the oldest and longest running relay races in the United States.

‘Tis the season to be red-eyed

Articles
It’s prime allergy season: Here’s a primer on what to advise patients with an itch to ditch.

Challenges faced in clinical trials for chronic allergic conjunctivitis

Articles
Among chronic diseases, allergy is documented as the fifth leading group affecting 50 million Americans.

Breaking Down the Enigma of Dry Eye

Articles
A look at the science behind the development of lifi tegrast, and
where it fi ts into the therapeutic puzzle.

ARVO 2015 meeting finds connections in innovative drug delivery, therapies

Articles
Cutting-edge progress also continues in retina, cornea, dry eye, gene-based science

Staying Current With Apps

Articles
Retina specialists are finding that apps are not just for music and games anymore.

RISC and Reward with Inhibitory RNAs

Articles
A new understanding of ribonucleic acid’s activity in cells may
lead to breakthroughs in ophthalmic treatment.

Speaking With Patients About Premium IOL Clinical Trials

Articles
Section Editor Ryan Bouchard interviews John Berdahl, MD.

Delivering a Rocky Mountain ARVO

Articles
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.

Ocular Therapeutix™ Begins Enrollment in Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis

Articles, News
Phase 3 Allergy Program Establishes Clinical Indication Expansion Strategy of DEXTENZA™

The Secrets of Ocular Microbiomes

Articles
The placid ocular surface is actually teeming with life that might
hold the secret to treating ophthalmic disease.

Advances in pharmacotherapy for allergic conjunctivitis

Articles
Allergic conjunctivitis is a common and potentially debilitating condition affecting
the conjunctiva, eyelids and cornea, and it is often associated with nonocular symptoms
and signs of rhinitis or sinusitis.

Another great year at ARVO.

Articles
See you next year in Seattle!

Portola Pharmaceuticals Announces Collaboration With Ora, Inc. for Syk-selective Inhibitor (PRT2761) in Ophthalmic Diseases

Articles, News
Collaboration Allows Portola to Advance Product Candidates Outside of Core Focus

Avoiding Protocol Deviations In Clinical Research

Articles
Deviations should be rare. The protocol helps
to keep the study on track.

A Stepwise Approach To Acute Dry Eye

Articles
How to approach the occasional situation in which this chronic condition suddenly becomes acute.

Identifying and Filling the Unmet Need

Articles
Ophthalmic Product Development Insights

Quarterly Ora Newsletter – May 1, 2015

Articles, News
Customer Success Stories: Celebrating Your Big Wins in 2014-2015

Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome

Articles, News
SkQ1 is the first mitochondria-targeted antioxidant to reach clinical phase of development for an ophthalmic indication

RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S.

Articles, News
U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc.

The Logistics of Participating in Device Clinical Trials

Articles
Communication and proper preparation are necessary for a successful study.

Gene Therapy for Retinal Diseases

Articles
The eye is an ideal target for gene therapy.

Clinical Advances in Ocular Allergy

Articles
Researchers
are exploring
disease-modifying
treatment options
and not just
symptomatic relief.

Hopes and Hurdles for Stem Cell Therapy

Articles
The exciting world of stem cell therapy is the cutting edge of
medical research. Here’s how it intersects with ophthalmology.

Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule

Articles
Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule

Anti-allergic agent alcaftadine stronger in relief of ocular itching

Articles
Data may influence prescribing habits and formulary availability in future allergy seasons

Biocube allergen chamber study to start for new therapeutic for rhinitis indication

Articles
Clinical trial for the treatment of allergic rhinitis for 3E Therapeutics Corporation

Sampling New Targets for Allergy Therapy

Articles
Learning more about ocular allergy has revealed a host of potential allergic mediators for researchers to attack.

Funding Strategies for a Retina Program

Articles
To facilitate a costly, and generally lengthy, drug development process, it is crucial to have an established, well-thought-out financing plan to ensure adequate funding.

The Preclinical Process: Drugs Designed for the Back of the Eye

Articles
Preparation for preclinical stages of drug development could have implications for postmarketing success.

Putting Your Contacts to Work

Articles
Attempts to engineer contact lenses that also elute therapeutic drugs face hurdles in both the world of lenses and of drugs.

The Scientist-Entrepreneur as CEO

Articles
Scientist-entrepreneurs often feel as if nobody knows their product better than they do.

BioLight Reports Positive Clinical Study Findings for its TeaRx™ Diagnostic Parameters for Dry Eye Syndrome

Articles
Positive statistical correlations were identified

Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye

Articles
Different patterns of keratitis provide clues to the underlying disease, whereas
different amounts are indicative of severity.

Optimizing Reading Tests for Dry Eye Disease

Articles
Results showed significantly lower rates in all reading tests in subjects with dry eye than in normal subjects

The Other Side of the Cornea

Articles
The endothelium can begin to falter from disease, but there are methods in development to help restore it.

Two Decades In Translation

Articles, News
For 20 years, “Therapeutic Topics” has explored ocular disease. Here’s an update on where translational medicine stands today.

Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops

Articles, News
Dry Eye Syndrome, results expected in Q3/2015

Breaking Into the Medical Device Industry

Articles
Product development pathways for devices in the United States.

Dry eye therapy seeks to fill unmet need in artificial tears

Articles
A look at the history of artificial tears traces progression of products, dry eye market

The Clinical Data Management Process

Articles
Efficient collecting, transferring, and managing of data during a clinical trial is important and
helps advance the drug development process.

3,500 Years of Artificial Tears

Articles
After three millennia of battling the discomfort and irritation of dry eye, is ophthalmology any closer to a solution?

Ora-CAC®Model Provided Platform for Recent Positive Phase 2 Data for Ocular Therapeutix’s OTX-DP in Allergic Conjunctivitis

News
A drug-eluting punctum plug being evaluated by Ocular Therapeutix

Nicox’s shareholders approve acquisition of Aciex Therapeutics, Inc.

Articles, News
The acquisition of Aciex represents a significant step forward in Nicox's strategy of creating an international ophthalmic company

RegeneRx Allowed to Proceed with Phase 3 Using RGN-259 Eye Drops for the Treatment of Neurotrophic Keratopathy

Articles, News
Continuing to show positive results in Phase 3 will be an important breakthrough for treating NK

Guidelines for Writing Protocols

Articles
The protocol is the operating manual for a clinical trial, and every detail must be considered.

Leveraging Ex-U.S. Deals

Articles
Through this brief column, we hope that you'll continue to glean a few insights that may help your ophthalmic program best navigate early stage business planning and development

Thoughts on Healing the Wounded Cornea

Articles, News
A look at the mechanism behind neurotrophic keratitis as well as current and future methods for treating it.

A Close Look at Pseudoexfoliation

Articles
This disease is linked to vision loss, hearing loss and cataract. Learning more about it may help lead to better treatments.

The Basics of a Pre-IND Meeting

Articles
Meetings with regulatory boards provide guidance to researchers who seek to comply with regulatory requirements and ease the drug approval process.

Acquisition of Boston biotech for up to $120M a ‘validation’ of Ora’s model

Articles, News
French drug developer NiCox S.A. last week announced plans to buy Aciex Therapeutics

Nicox to acquire Aciex Therapeutics, Inc.

Articles, News
Significant step forward in Nicox's strategy of creating an international ophthalmic company built around therapeutics and diagnostics

ARVO Comes to The City of Magic

Articles
Highlights from the posters and papers presented at the 2014
ARVO meeting in Orlando.

Including Clinical Trials at Your Practice

Articles
First-time investigators should consider several matters when preparing for a clinical trial.

Resistance Fighters: An Antibiotics Update

Articles
Antibiotic innovation has slowed, allowing drug resistance to catch up, but there is still hope for the future of anti-infectives.

Innate Immunity: A Question of Balance

Articles
A look at the processes of immunity and ocular inflammation,
and new avenues for disease therapy.

It all adds up to Ora

Articles, News
Check out our latest Video

Clinical Innovations

Articles
The challenges and opportunities health care companies are facing regarding innovation in clinical trials and product development

Mitotech S.A. announces the initiation of phase ii clinical trial in dry eye patients utilizing the controlled adverse environment

Articles
SkQ1 proven effective in a topical ophthalmic formulation at preclinical stage of compound development

Ophthalmology Innovation Summit At ASCRS 2014

Articles, News
The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation

A Recipe for Better Patient Compliance

Articles
How different drug formulations and dosing regimens may help ensure that patients take their medicine.

Running a Tight Ship

Articles
Pearls for Conducting a Clinical Trial

Pediatric Studies in the Retina Space

Articles
Pediatric trials present unique challenges during the recruitment and treatment phases.

Don’t Olympic curlers ever blink?

Articles
A recent interview with Dr. Abelson in the Toronto Star discussing the science of blink behavior of Olympic curlers.

Wise Choices for Ocular Diagnoses

Articles
A look at the value and utility of a range of diagnostic
techniques and technology for anterior segment disease.

Systemic Rxs And Ocular AEs

Articles
When a patient is taking drugs systemically, here are the ocular
adverse events to be on the lookout for.

Cool Opportunities to Modulate Nociception

Articles
A breakdown of the corneal nerves, how they’re stimulated and
how dry eye, trauma and contact lenses affect them.

So you want to run a research site?

Articles
Recruiting patients for a study doesn’t have to be trail in itself.

Phases of Reactions: Keys to Diagnosis

Articles
Identify telltale sign and symptoms of early- and late- phase allergic reactions can expedite you diagnosis.

What to do when you see red

Articles
Here’s what you should know about treating ocular Hyperemia and its underlying cause.

20 years of research and 10,000 patients: Ora dry eye system supports two largest exits in dry eye

Articles, News
Unprecedented year sets Ora up for record 2014

Intellectual property within the context of establishing and protecting market share

Articles, News
Ophthalmic Product Development Insights

Dry-Eye Tests: Reading Is Fundamental

Articles
A look at the damage dry eye causes and how reading tests
might be good gauges of the disease’s clinical effects.

The Modern Wisdom Of Clinical Models

Articles
How models of disease, carried out in the clinic, can yield
useful information about an ailment and treatments for it.

What’s the Plan?

Articles
Ophthalmic Product Development Insights

A Street-Level Look At Urban Allergy

Articles
How living in an urban environment may foster an allergic
response and the potential treatments waiting in the wings.

Study Participant Retention in Clinical Trials

Articles
business of retina clinical trials for the retina specialist

An update on ocular allergy trends

Articles
Ocular symptoms of allergic conjunctivitis are common and quite often interfere with quality of life for affected individuals.

What considerations are there for financing?

Articles
Ophthalmic Product Development Insights

Acupuncture: A Dry-Eye Therapy?

Articles
This ancient medical art may have some usefulness for patients
seeking alternative ways to treat their disease.

Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)

Articles, News
Compound May Offer New Treatment Option for Millions of Patients with DES

ARVO Goes to The Emerald City

Articles
Highlights from the papers and posters of ARVO’s first foray
outside of the balmy borders of Florida.

ARVO: Sight set on world-class science

Articles, News
Theme of ‘life-changing research’ provides current data on retina, glaucoma, dry eye, and more

Automated grading system for evaluation of ocular redness associated with dry eye

Articles
We have observed that dry eye redness is characterized by a prominence of fine
horizontal conjunctival vessels in the exposed ocular surface

Alternative Therapy: Good, Bad or TBD?

Articles
Natural therapies may have some benefi t for patients, but it
pays to be aware of what can go wrong, as well.

ARVO 2013

Articles
Our 20 Ophthalmic focused poster presentations are now available for download

When do I go to meet with FDA?

Articles
Ophthalmic Product Development Insights

New Therapies: Of Kinases and Cascades

Articles
How various kinases act within the eye and the potential for
targeting them to produce therapeutic results.

Dry Eye – Special Report

Articles
Working to complete the dry eye therapeutic story

Subject Recruiting

Articles
The backbone of any clinical trial

Sorting Out the Stats from the Jaks

Articles
The 20th anniversary of a landmark scientific discovery provides
an opportunity to look into the future of ocular therapies.

Setting Eligibility Criteria

Articles
Clinical Trials for the Retina Specialist

Begin with the End in Mind

Articles
Ophthalmic Product Development Insights

The Pillars of Ocular Surface Pathology

Articles
An in-depth look at the two conditions common to many
patients: allergic conjunctivitis and dry eye.

Medical Device Regulation: A Review

Articles
Business of retina clinical trials for the retina specialist

Ophthalmic Product Development Insights

Articles, News
We talk to many ophthalmologists and physician-scientists whose interactions with patients, understanding of clinical practice and therapeutics lead to an “idea.”

Aciex Enters Into Collaborative Research Agreement with Portola to Develop Dual Syk/JAK Inhibitors for Ophthalmic Indications

Articles, News
Ora will provide clinical development and regulatory consulting services to the collaboration.

The Drug Development Path

Articles
Business of retina clinical trials for the retina specialist

Nobel Therapeutics And Ophthalmology

Articles
How the subject of Nobel-Prize-winning, landmark scientific
research is making its way into our patients’ eyes.

Bausch + Lomb Licenses New Technology with Potential to Treat Millions Affected by Ocular Redness

Articles, News
May Offer Faster, More Effective, Longer Lasting Relief

Glaucoma Therapeutics 2013

Articles
A look at the safety and efficacy of various therapies for the disease, from pharmaceuticals to surgical implants.

Pre-clinical models

Articles
Ora’s pre-clinical group is busy developing a number of animal models of ocular disease to use in early stages of the development and candidate drug screening process.

Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy

Articles
The goal of this study was to assess the effect of a controlled adverse environment (CAE) challenge

2012: Completing the premium surgical suite picture

Articles
Technologies such as femtosecond lasers, OVDs optimize patient satisfaction, outcomes

In vivo Confocal Video-Microscopy

Articles
Real-Time Dry Eye and Allergy Assessment

Glaucoma therapeutic update

Articles
Treatment strategies for primary open-angle
glaucoma focus on reduction in IOP

2012: Year for retina approvals

Articles
Advances include treatments for CRVO, DME , VMA; many prospects in pipeline

Electronic Filing, The Deadline is Approaching

Articles, News
For over 10 years the FDA has been accepting electronic submissions of regulatory documents.

Bringing the Focus To the Aqueous

Articles
A look at the composition of our tears and the pros and cons of
our current methods of tear measurement.

Where Are We With Therapeutic Approaches for Retinal Vascular Diseases?

Articles
One Year After Aflibercept

Prime Factors of Ocular Allergy

Articles
A guide to understanding the process known as allergen
priming, which plays a key role in allergic conjunctivitis.

The Antimicrobial Evolution

Articles
With several new therapies in the pipeline, practitioners may soon have a
new arsenal of drugs to better treat ocular infections.

Staying Local with Blepharitis Treatment

Articles
Ways to diagnose and categorize the disease, and thoughts on the best way to treat it when it occurs.

Adopting and Adapting Imaging Tools for Clinical Use

Articles
Imaging advances are providing entirely new ways of capturing the human eye and visualizing ocular structures and disorders.

Seeing the Future of Ocular Imaging

Articles
The latest imaging technology can help eye care practitioners better assess and treat
corneal complications.

Of Biomes, Biofilm and The Ocular Surface

Articles
Knowing how bacteria grow and communicate may hold the
key to future treatments for ophthalmic infections.

A Preemptive Strike

Articles
Open communication with your patients can help to alleviate complications
surrounding dry eye and contact lenses, such as dropouts.

Ora in India

Articles
Ocular therapeutics is a global business so it’s no surprise that current Ora projects include studies around the world.

Clinical Trials from the Statistician’s Side: Reducing Variability

Articles
When minimizing variability in retinal imaging data for a clinical trial, there exists a “uniform operations chain” consisting of the machine, operator, and reading center.

Combination a complication

Articles
Allergic conjunctivitis and dry eye: Co-morbid partners of ocular surface disease

Vasoconstrictors: Myths and Realities

Articles
The facts about how vasoconstrictors work and thoughts about mechanisms behind their purported negative side effects.

Farewell, Fort Lauderdale

Articles
‘Translational research: Seeing the possibilities’ focus of finale in Florida host city

ARVO 2012 Gives Florida Our Best

Articles
Highlights from the final Fort Lauderdale meeting of the
Association for Research in Vision and Ophthalmology.

Pre-Surgical Steps for Your Patient

Articles
By addressing ocular surface disease in pre-operative patients, you can pave the way
for a smooth surgery.

Recruiting for Invasive Clinical Trials

Articles
clinical trials for the retina specialist

A Patient’s View of Dry-Eye Disease

Articles
A look at what a patient's blink tells us about dry eye, visual acuity and even general fatigue.

The Allergens of Perennial Disease

Articles
Though the change of seasons give some allergy sufferers a respite, some allergens show no mercy.

‘Resolving’ the Effects Of Fish Oil on the Eye

Articles
A look at how fish oil provides benefits to ocular health, and the
promise offered by new fish-oil-derived molecules, resolvins.

Dry Eye Brimming With Innovation

Articles
From the therapeutic pipeline to diagnostic models and technologies

AK: Let’s Shift the Blame

Articles
Acanthamoeba keratitis is not limited to contact lens wear.

The mechanism of a Pollinosis Diagnosis

Articles
An update on how allergens attack the eye and how that knowledge can help us develop better treatments for allergy,

Clinical Endpoints for Retinal Disorders

Articles
Business of Retina Clinical Trials For The Retina Specialist

The Other Side of the Lens

Articles
Practitioners should keep tabs on new contact lens innovation such as drug delivery.

Translating Clinical Trial Results to Practice

Articles
The clinical research process that takes a promising new treatment from initial investigation through US Food and Drug Administration (FDA) approval

Spring Into Action this Allergy Season

Articles
With seasonal allergies expected to start earlier this year, it’s never too soon to make
sure you’re up to date with the latest treatment options.

Unmet need spurs research

Articles
Therapy for chronic ocular allergy a major focus for drug development

VKC and the Allergy Rogues Gallery

Articles
What sets vernal keratoconjunctivitis apart from other allergic conditions, and how to create targeted treatments for it.

Therapies offer relief to many patients

Articles
Treatments for ocular allergy have come a long way, but still have miles to go

Treating the Problem: Fungal Keratitis

Articles
Stay up-to-date on the current treatment regimens and future therapies for fungal keratitis infection.

Anti-VEGF State of the Union

Articles
Business of Retina Clinical Trials for the Retina Specialist

Acanthamoeba Creeps into the Light

Articles
Clearing up misconceptions about the Acanthamoeba infection in light of recent outbreaks.

RegeneRx Reports Positive Data with RGN-259 in Phase 2 Dry Eye Trial

Articles, News
A sterile, preservative-free eye drop, to evaluate its safety and efficacy for the treatment of signs and symptoms of dry eye

Fungal Keratitis: The Lessons Learned

Articles
Eye care practitioners should be able to quickly identify and treat keratitis outbreaks
in their patients.

Validation and Verification of the Allergen Biocube Model with an Intranasal Corticosteroid

Articles
Controlled clinical models have become an important tool in development and regulatory approval of new therapeutics for allergic rhinitis.

The Renaissance of Drug Delivery Systems for the Posterior Segment

Articles
Business Of Retina Clinical Trials For The Retina Specialist

First Patient Enrolled in SARcode Bioscience’s Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution

Articles, News
SAR 1118 is a first-in-class molecule that inhibits T-cell inflammation by blocking the binding of two key cellular surface proteins

Clinical Trials in the Anti-VEGF Era

Articles
Despite the obvious benefits of anti-VEGF therapy, there is still a significant unmet need for better treatments for wet AMD and DME.

RegeneRx completes patient recruitment in Phase 2 dry eye drug trial

Articles, News
Double-masked Phase 2 trial to evaluate the safety and efficacy of RGN-259 as a treatment of dry eye syndrome

Akorn Acquires Minority Stake in Ophthalmic Drugs Firm Aciex

Articles, News
Firms in addition ink manufacturing agreement for one of Aciex's lead prescription candidates.

Euclid Systems partners with Ora, Inc. for development of its novel collagen-based drug delivery system for glaucoma treatment

Articles, News
Ora operates a clinical research facility and a large international investigator network.

It is Time to Think About the Blink

Articles
In addition to defending the eye from particles and allergens, the blink can help diagnose
certain diseases as well.

Dry-Eye Studies: Beware These Pitfalls

Articles
Everything from environmental and seasonal factors to the placebo effect can confound a study’s results.

The Foolish Things Patients Do

Articles
Practitioners should educate their patients about the common and uncommon
everyday risks of injury to the eye.

Glaucoma and Dry Eye: A Tough Combo

Articles
How chronic glaucoma treatment can give rise to ocular surface disease, and how you can treat them both.

First Study Visit Success

Articles
Business of Retina Clinical Trials for the Retina Specialist

Breaking Down the Blink

Articles
How the eyeblink affects the corneal surface and what factors impact our blink rate.

Methodologies for the Study of Ocular Surface Disease

Articles
The ability to obtain reliable results from clinical trials of therapies for ocular allergic disease and dry
eye disease is often limited because of inadequate control of variables.

Download the Clinical Development Services PDF

Download